FDA Advances Rare Disease Drug Development with New Evidence Principles

FDA Press Announcement | September 3, 2025

The FDA introduced the Rare Disease Evidence Principles to provide greater speed and predictability for therapies intended for very small rare disease populations with significant unmet need. The announcement specifically highlights clearer guidance on the kinds of evidence that may support approval in these settings.